We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
Advertisement
 

RELATED ARTICLES

64 Human Genomes Sequenced as a New Reference for Genetic Variation

News

Researchers have detailed the sequencing of 64 full human genomes. This will enable studies on genetic predispositions to human diseases as well as the discovery of more complex forms of genetic variation.

READ MORE

A New Realm of Drug Discovery Utilizing Ubiquitin Ligase

News

UNLV scientist Gary Kleiger is at the forefront of a potential new drug modality; research published in the journal Nature.

READ MORE

Metabolic Pathway for Memory T-Cell Production Mapped

News

Immunologists have mapped the previously unknown biological machinery by which the immune system generates T cells that kill bacteria, viruses and tumor cells. The findings have multiple implications for how the adaptive immune system responds to infections to generate such memory T cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE